Introduction {#s0005}
============

Exposure to microgravity has been recognized as a major environmental factor of spaceflight. Some of the adverse effects resulting from spaceflight are a decline in cellular immune response [@bib1], [@bib2], [@bib3], cardiovascular deconditioning [@bib4], bone deterioration [@bib5], and muscular atrophy [@bib6]. Elucidation of the molecular mechanisms underlying microgravity-induced health problems is critical for formulating effective counter-measures for spaceflight side-effects. Due to the cost effectiveness and the ability to separate microgravity effect from other complex factors of spaceflight, ground-based simulated microgravity (SMG) research has become popular and is widely practiced in space life sciences research.

Ground-based SMG conditions for mammalian cell and microorganism cultures are created through the use of high aspect ratio vessel (HARV) bioreactors [@bib7], [@bib8], which simulate microgravity by maintaining the cells in continuous free fall in liquid medium and are most commonly used in the United States [@bib9], [@bib10], [@bib11], [@bib12]. The HARV bioreactor does not allow the cells to receive a gravitational load in any fixed direction. Its constant rotation does not eliminate gravity, but it does allow the *g*-vector to be time-averaged to near zero [@bib13]. Ground-based SMG experiments using bioreactors such as HARV have become increasingly recognized as an effective approach in simulating certain aspects of microgravity, as it readily permits the more detailed experimentation towards the understanding of microgravity effects on genes and cellular activities during microgravity exposure.

Understanding gene and cellular activity changes in microgravity is essential for tackling the problems caused by microgravity exposure and for developing potential countermeasures. Studies at the cellular and molecular levels have been reported from both spaceflight and ground-based microgravity simulators such as HARV [@bib10], [@bib14], [@bib15], [@bib16], [@bib17]. Microgravity has been found to influence major cellular events such as cell proliferation, cell cycle, cell differentiation, and programmed cell death [@bib18], [@bib19], [@bib20]. Many cell types, ranging from bacteria to mammalian cells, are sensitive to the microgravity environment, suggesting that microgravity affects fundamental cellular activities. The study of microgravity effects on cellular activities can benefit enormously from genome-wide gene expression technologies.

Gene expression profiling based on DNA microarrays is a genome-wide gene expression analysis method for assessing cellular and molecular activity changes in response to a change in the growth environment. Environmental change as drastic as sudden gravity change is likely to alter the functions and transcriptional activities of groups of genes. A genome-wide display and comparison of gene expression profiles in cells that are exposed to microgravity and different recovery stages could provide great insight into the array of genes that are directly or indirectly involved in gravity response. This is because any change in the physiological activity of a cell is most likely the result of changes in the expression of certain genes. Thus, the genome-wide expression analysis technology can be a powerful tool to identify the "space genes" that play key roles in cellular response to a microgravity environment. In recent years, microarray technology has become increasingly popular in space biosciences research and most of the microgravity-induced cellular and molecular effects have been reported on cells of the immune system [@bib21], [@bib22], muscle [@bib23], [@bib24], [@bib25], [@bib26], and bone [@bib12], [@bib27], [@bib28], [@bib29], [@bib30]. However, it is not clear if the affected cellular functions would recover once the cells are returned to 1 *g* conventional growth conditions.

To further understand the cellular and molecular mechanisms by which spaceflight alters cellular activities, the effects of microgravity on various human cell lines should be studied to identify the genes whose functions are most consistently affected by microgravity. Epidermal keratinocytes, the major cell type in the outermost layer of the skin, play an essential role in the first-line defense against invading microorganisms and in innate immunity [@bib31], [@bib32]. To date, the molecular effect of microgravity on keratinocytes is not known. Thus, the aim of this study was to display time course gene expression profiles and identify key gravity sensitive genes for human kerotinocytes in response to microgravity. We studied the microgravity effect on a basal-like type of immortalized human epidermal keratinocytes, HEK001, using the HARV bioreactor SMG system. We applied DNA microarray analysis for genome-wide expression profiling of the cells exposed to HARV bioreactor SMG conditions for 3, 4, 9, and 10 d, followed by recovery of 15, 50, and 60 d at 1 g. Our results indicated that cellular gene activity achieved \>80% recovery from the shorter exposure time (≤4 d) in a recovery period of 15 d, while a longer recovery period (≥50 d) was needed for genes to recover to the shorter exposed impact levels after an exposure time as long as 9 and 10 d. In addition, we have identified 32 putative "major space genes" that were most consistently affected by SMG through the interlinked time course analysis. Interestingly, a cluster of eleven genes that are inducible through the integrated stress response pathways were all down-regulated in the presence of SMG. In contrast, a cluster of seven metallothionein genes were up-regulated through all the time points. Moreover, HLA-G, a key gene that mediates cellular immune suppression effect, was up-regulated during the recovery phase of SMG exposure. Our findings contribute significantly to the knowledge of epidermal response to SMG, which may suggest a mechanism in the whole body response to microgravity, particularly in microgravity-associated immune response suppression, integrated stress response, and tumor progression.

Results {#s0010}
=======

Morphology of HEK001 cells cultured in HARV bioreactors and in conventional 2D cell culture flasks {#s0015}
--------------------------------------------------------------------------------------------------

Monolayer keratinocytes, HEK001 cells, formed small aggregates and spherical cellular morphology ([Figure 1C and E](#f0005){ref-type="fig"}) typical for cells cultured in the 3D environment of HARV bioreactors. When the HEK001 cells were removed from the HARV bioreactors after the shorter (3 and 4 d) SMG exposures and then cultured in conventional 2D cell culture flasks for 15 d, the keratinocytes spread out to form monolayer growth indistinguishable from the untreated controls (compare [Figure 1A and B](#f0005){ref-type="fig"} with [D and F](#f0005){ref-type="fig"}). Cells from the longer (9 and 10 d) SMG exposures were not recovered as complete as the shorter ones, and elongated cells were found in the recovery culture after 16 d ([Figure 1G and H](#f0005){ref-type="fig"}). [Figure 1G](#f0005){ref-type="fig"} shows cells after 7-day recovery from a 9-day SMG treatment; note that cell aggregates were visible at the early recovery stage. Although these cells regained their morphological appearance after extended culturing under normal gravity, the extent to which cellular gene activity was affected by the SMG treatments and whether the altered gene functions would ever recover were of crucial interest. Therefore, we next investigated through DNA microarray analysis for genome-wide gene expression evaluation and through Northern blotting for gene-specific validation.

General gene expression profiles and distributions of the time course microarray data {#s0020}
-------------------------------------------------------------------------------------

To visualize the general gene expression profiles of the microarray data, we first plotted the extracted microarray data in MA plots ([Figure 2](#f0010){ref-type="fig"}). In the MA plots, each point represents one feature from a corresponding microarray. The plots of five different microarray experiments before and after normalization show the general gene expression profiles of the cells exposed to different doses of SMG and during different recovery periods (Arrays 1−5; [Figure 2A−E](#f0010){ref-type="fig"}). After normalization and statistical analysis (student *t*-test) of the microarray data, a total of 314 differentially regulated genes from the five time course microarrays were identified as statistically significant (*p* ≤0.05). We further filtered the 314 genes to a cut-off point of 1.5-fold up- or down-regulation. Thus, a total of 162 genes were identified from the five SMG experiments to be significantly (≥1.5-fold change, *p* ≤0.05) differentially expressed, constituting the initial pool of the putative gravity sensitive genes in the SMG-treated keratinocytes (see [Table 1](#t0005){ref-type="table"} in [Appendix](#s0100){ref-type="sec"}). The numbers of differentially regulated genes allocated for each of the five (Arrays 1−5) microarrays were 101, 94, 18, 105, and 86, respectively. These putative gravity sensitive genes of the keratinocytes were subjected to further bioinformatics analysis.

Functional grouping and time course expression profiles of the 162 gravity sensitive genes {#s0025}
------------------------------------------------------------------------------------------

The significantly differentially expressed genes in each of the five experiments were further categorized into 18 functional groups using histograms as shown in [Figure 3](#f0015){ref-type="fig"}. For each experiment, the number of genes induced (red) and suppressed (blue) was graphed for each of the 18 functional categories, generating an individual histogram profile for the corresponding microarray. [Figure 3A](#f0015){ref-type="fig"} shows the functional distribution of 101 SMG-affected genes exposed to 3-day microgravity (Array 1) with 34 induced and 67 suppressed. Those exposed to 4-day SMG (Array 2) exhibited a similar expression pattern, with 32 genes up-regulated and 62 down-regulated ([Figure 3B](#f0015){ref-type="fig"}). In contrast, the cells that were cultured for 4-day SMG and then re-cultured and grown at 1 *g* for 15 d recovered from the microgravity effect more efficiently, with only 18 genes exhibiting significant differential regulation (10 up and 8 down) ([Figure 3C](#f0015){ref-type="fig"}). The cells that were grown in SMG for 9 and 10 d followed by recovery culturing at 1 *g* for 50 and 60 d, respectively, exhibited a similar expression pattern to each other and to the first two time points (compare [Figure 3D and E](#f0015){ref-type="fig"} with [A and B](#f0015){ref-type="fig"}). The effect of the longer exposures followed by the near two-month recovery time seemed to be equivalent to the shorter exposures without recovery. Most notably across the four similar profiles ([Figure 3A, B, D, E](#f0015){ref-type="fig"}), cellular functions affected by SMG mainly were metabolism, cell communication, cell development, and cell death. The data suggest a critical role of the recovery growth in mitigating the alteration of cellular gene functions from prolonged SMG exposure. The recovery effect was even more apparent in Array 3 ([Figure 3C](#f0015){ref-type="fig"}), which showed that only 18 genes were differentially expressed compared with the non-treated control, while \>80% of the genes had returned to homeostasis after 15-day recovery in normal gravity.

Cluster analysis of genes differentially expressed under microgravity and recovery {#s0030}
----------------------------------------------------------------------------------

The 162 differentially regulated genes were clustered hierarchically into five clusters ([Figure 4](#f0020){ref-type="fig"}; [Table 1](#t0005){ref-type="table"}) using average-linkage clustering [@bib33]. Cluster I was coordinately down-regulated, consisting of 14 genes, 11 of which were from the integrated stress response pathway. The genes in Cluster I from the cells cultured for 3 d (Array 1) and 4 d (Array 2) in SMG were on average down-regulated \~3.8 fold. When allowed to recover at 1 *g* for 15 d (Array 3), \>80% of these genes recovered to non-exposed level. The genes that were exposed to SMG for 9 and 10 d and were allowed to recover at 1 *g* for 50 d (Array 4) and 60 d (Array 5), respectively, showed a level of down-regulation similar to those exposed to SMG for 3 and 4 d. Cluster II has 83 genes. The expression pattern was very similar between 3-day and 4-day SMG, with the average down-regulation of \~1.7 fold, and similar between 9-day and 10-day SMG followed by 50-day and 60-day recovery at 1 *g*, respectively, with the average down-regulation of \~1.5 fold. This cluster did not show significant differential expression after exposure to 4-day SMG followed by 15-day recovery at 1 *g*. There are 17 genes represented in Cluster III. The average expression level for 3-day and 4-day SMG exposure was \~2 fold. Again, this cluster did not show significant differential expression after exposure to 4-day SMG followed by 15-day recovery. Cluster IV is comprised of eight metallothione genes that were all up-regulated across the five time points. The level of up-regulation was \~2 fold across the first three time points. After 9-day SMG followed by 50-day recovery, the Cluster IV gene expression increased to \~4-fold up-regulation. After 10-day SMG followed by 60-day recovery, however, the Cluster IV gene expression returned to the level similar to the levels of the shorter exposure time points (\~2-fold up-regulation). It may be that an additional 10 more days' recovery time was needed to allow the longest exposed cells to recover to the impact level of shorter exposed cells. In Cluster V (40 genes), there was an average up-regulation of \~1.5 fold after 3-day and 4-day SMG and a drop to little (no differential regulation or complete recovery) after 15-day recovery. However, for 9-day and 10-day SMG followed with recovery at 1 *g* for 50 and 60 d, it showed a similar expression pattern (\~1.6-fold up-regulation) to those cultured under SMG for 3 and 4 d. Thus, the close to two-month recovery time again reduced the SMG effect to the level of shorter exposures for the 40 genes in this cluster.

Overlapping patterns of differentially expressed genes among the five SMG experiments and the identification of "center genes" {#s0035}
------------------------------------------------------------------------------------------------------------------------------

When comparing Arrays 1 and 2 for the 3-day and 4-day SMG ([Figure 5A](#f0025){ref-type="fig"}) using the Venn diagram, we found that a total of 76 differentially regulated genes (27 up and 49 down) were common to both microarrays, showing a consistency of \~75% between the two different time points. A total of merely 18 differentially expressed genes in Array 3 indicated that \>80% of the genes had recovered from the 4-day microgravity effect after 15 d in normal gravity culture. Out of these 18 significant genes, there were 17 and 16 genes shared with the 3-day and 4-day microgravity treatment alone, respectively; this constituted about 90% of all the significant genes identified from Array 3. The data suggest a causal link for the remnant SMG affected genes, which resulted from having not yet completely recovered from the SMG treatment. [Figure 5B](#f0025){ref-type="fig"} allowed us to further compare the expression patterns between the shorter exposures alone and the longer exposures followed with up to a two-month recovery period (Arrays 4 and 5). We found a significant overlap of the differentially regulated genes among the four different time points. Similar to the two shorter exposures (3-day and 4-day SMG) shown in [Figure 5A](#f0025){ref-type="fig"}, the two longer exposures (plus longer recovery) shared \~69% common differentially expressed genes. An important function of the Venn diagram is that it allowed us to readily identify the genes affected by all the SMG treatments through the center of the diagrams: all four time point microarrays shared 32 genes (13 up and 19 down) that are differentially regulated by at least 1.5 fold ([Figure 5B and C](#f0025){ref-type="fig"}). These "center genes" were the best candidates for the "major space genes" because they were most consistently affected by SMG.

Validation of microarray results through Northern blotting analysis of ten cellular genes {#s0040}
-----------------------------------------------------------------------------------------

We also performed Northern hybridization to verify the results from the microarray analysis of the SMG time course experiments. The uniqueness of Northern blotting analysis is that it measures the abundance as well as the size of the RNA of interest [@bib34]. [Figure 6](#f0030){ref-type="fig"} shows the size identity and expression levels for ten genes, nine of which were significant genes identified through microarray experiments, and GAPDH was used as an internal control. The Northern hybridization reactions were performed sequentially with the ten cDNA probes as shown in the figure. All the hybridizations shown in the figure resulted in one predominant band of the expected sizes (marked with arrows) for the particular mRNAs. However, some minor bands were visible in a few panels. For the TRIB3 probe, the level of the larger band (\~2,500 to 2,800 bp) was down-regulated in SMG; the expression level for another isoform (alternatively spliced) of TRIB3 mRNA ([Figure 6C](#f0030){ref-type="fig"}) did not seem to be affected by SMG. There was a higher band found in lanes 1, 4, and 5 of [Figure 6G](#f0030){ref-type="fig"} (MT1A probe), which most likely resulted from the incomplete stripping of the TRA1 probe hybridized immediately prior to the hybridization of MT1A.

The bands of the expected sizes for the probed mRNA (marked with arrows) were subjected to quantitative analysis. To quantitatively analyze the mRNA levels from the Northern blots, we first normalized all the mRNA bands in [Figure 6A−J](#f0030){ref-type="fig"} against the GAPDH level in each corresponding lane. The normalized levels of the mRNA in each panel were then plotted in histograms as shown in [Figure 7](#f0035){ref-type="fig"}. The overall Northern blotting results demonstrated a remarkable resemblance to those obtained from microarray analysis, with an overall high level of correlation between the results from the two methods (R=0.86; [Figure 7](#f0035){ref-type="fig"}). The mRNA levels for genes PDIA4, TRIB3, AREG, TRA1, PCK2, and ARMET were shown to be decreased significantly by both microarray analysis and Northern blotting, with correlation coefficient values of 0.97, 0.84, 0.98, 0.69, 0.91, and 0.93, respectively. The MT1X, MT2A, and MT1A mRNA levels were found to be significantly increased by both microarray and Northern blotting analysis, with correlation coefficient values of 0.58, 0.85, and 0.97, respectively. The overall high level of correlation (R=0.86) between the analytical results from microarray and Northern blotting further validated our genome-wide analysis using the microarray technology.

Discussion {#s0045}
==========

Microgravity effects have been closely associated with bone loss, muscle atrophy, and decreased immune function of astronauts. Consequently, extensive studies on cells of the bone, muscle, and blood origin have been documented in literature [@bib18], [@bib19], [@bib20]. Since astronauts experience whole body exposure to microgravity, all the organ systems in the body are potentially affected by the gravity change and may function differently to counterbalance the microgravity stress. The different organ systems may react differently to gravity change. It is also possible that a common set of genes in different cell lineages are preferentially altered in microgravity conditions. To fully understand the microgravity effect on human health, it is important to study the microgravity response of cells of various organ origins. The identification of the common set of gravity sensitive genes may lead to the identification of "major space genes" that together play a major check-and-balance role ultimately determining the outcome of a cell, or an organism such as an individual person, in the response to microgravity conditions.

The gene expression profiles for the five time points were achieved mainly from the 18 functional groups of genes in histograms and hierarchical cluster analysis of all the 162 significantly differentially regulated genes. The nearly identical expression profiles between the 3-day and 4-day SMG treatment indicated a high level of consistency in the number and type of gravity sensitive genes between the closely spaced time points ([Figure 3A and B](#f0015){ref-type="fig"}). Similar expression profiles were also found between longer time points, that is, cells recovering from 9-day and 10-day SMG treatment in normal gravity for 50 and 60 d, respectively ([Figure 3D and E](#f0015){ref-type="fig"}). The validity of the microarray data was further confirmed with Northern blotting analysis of ten genes ([Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}). For SMG exposure time as short as 4 d, a 15-day recovery period resulted in \>80% of the SMG affected gene expression returning to homestasis (compare [Figure 3C](#f0015){ref-type="fig"} with [B](#f0015){ref-type="fig"}). A two-month recovery period mitigated the affected gene expression profile to that equivalent to the 4-day SMG exposure level. Thus, our expression profiling results suggest that the time duration of microgravity exposure as well as post-SMG recovery are critical determinants of the extent to which cellular gene expression is affected by SMG. The shorter the SMG exposure and the longer the recovery time, the better the recovery from the SMG stress. Based on our results, it is advisable that shorter mission duration time and longer recovery interval would be beneficial to astronauts' health.

We further identified 32 "key" or "center" gravity sensitive genes from the 162 significantly differentially regulated genes detected from the time course experiments. This was achieved by the use of Venn diagrams of the shorter SMG exposures (3-day and 4-day SMG) and the longer exposures (9-day and 10-day SMG followed by 50-day and 60-day recovery) locating the genes that were in the very center of the four interlinked time points ([Figure 5B and C](#f0025){ref-type="fig"}). These genes were considered to be most consistently impacted by the microgravity treatment because they were affected by all the interlinked time points of the SMG exposures. These key gravity sensitive genes may be candidates for the "major space genes" whose activities were most significantly affected by the SMG environmental factor and most likely play a determinant role coordinately on the outcome of the SMG exposure effects. Many of these genes were found to be coordinately regulated in specific clusters belonging to particular pathways and are known to be coordinately regulated in non-space environment. One of the most notable groups of coordinately regulated genes was the eleven "center genes" (AREG, HSPA5, HERPUD1, PDIA4, PCK2, SDF2L1, TRIB3, SREBF1, TRA1, ASNS, and ARMET) that all came from Cluster I and were all down-regulated in SMG ([Figure 5C](#f0025){ref-type="fig"}; [Table 1](#t0005){ref-type="table"}). These genes are known to be coordinately regulated in integrated stress response pathways such as the endoplasmic reticulum (ER) stress response pathway and the amino acid starvation response pathway [@bib35], [@bib36]. They are typically induced coordinately in the presence of ER stress or in response to amino acid starvation [@bib35], [@bib36]. It is not clear why these genes were all down-regulated under reduced gravity conditions. It maybe that microgravity is favorable for protein folding and transport, making the machinery for the ER protein unfold stress response pathway unnecessary. To our knowledge, this is the first report to connect this set of integrated stress response genes to microgravity response. Nonetheless, in a study comparing the gene expression from cells grown in microgravity on the space shuttle with those grown in SMG, TRA1 was found to be down-regulated for 5.5 fold and 1.2 fold, respectively [@bib37]. In agreement with the reported space shuttle and SMG results, TRA1 in our experiment was also down-regulated across all the time points (from \~3.2 fold to \~1.75 fold) in SMG. TRA1 has also been found to be up-regulated in a variety of tumor cells in response to glucose depletion, hypoxia, and decreased pH. Therefore, TRA1 seems to be implicated in cell immunity against cancer cells [@bib38].

Another group of coordinately regulated genes that were also found in the center of the four interlinked time points includes seven metallothionein genes (MT1A, MT1B, MT1G, MT1H, MT1X, MT2A, and a MT2A clone ENST00000245185) in Cluster IV. These genes were all major isoforms of metallothioneins and were up-regulated in all the SMG time points, even more significant during recovery periods ([Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}; [Table 1](#t0005){ref-type="table"}). Consistent with our result, MT1A and MT2A expressions have been found to be up-regulated in space-flown (16 d) rat skeletal muscles [@bib20]. MT-I and MT-II isoforms have very similar structures and functions and are coordinately regulated in most cells [@bib39], [@bib40]. They have cellular functions primarily in metal ion homeostasis, scavenging of ROS, redox status, immune defense responses, cell proliferation, and cell death [@bib40], [@bib41]. MT-I and MT-II are induced by most inflammatory or pathological stimulus such as proinflammatory cytokines and oxidative stress [@bib42]. In addition, our microarray data showed several genes involved in immune response such as HLA-G and IL-1*β* to be affected by SMG ([Table 1](#t0005){ref-type="table"}, Cluster V). Although IL-1*β* induction has been reported in a macrophage cell line in space [@bib43], it is not known whether HLA-G gene expression would be altered by microgravity. In normal gravity environment, HLA-G has been shown to have direct inhibitory effect on T, APC, and NK cell functions in the immune system and induces suppressor T-cells. HLA-G also plays a role in tumordriven immune escape mechanism of cancer cells during the later phase in host and tumor cell interactions [@bib44]. Our finding that HLA-G mRNA levels were up-regulated in microgravity-exposed keratinocytes may suggest an underlining mechanism for microgravity-associated immune response suppression.

Conclusion {#s0050}
==========

In summary, our results indicated that cellular gene activity achieved \>80% recovery from the shorter exposure time (≤4 d) in a recovery period of 15 d, while a longer recovery period (≥50 d) was needed for genes to recover to the shorter exposed impact levels after an exposure time as long as 9 and 10 d. Interestingly, a cluster of eleven genes in the integrated stress response pathway that are inducible by ER stress and amino acid starvation were all down-regulated in the presence of SMG. In contrast, a number of genes involved in proliferation, development, and cancer were up-regulated. A cluster of seven metallothionein genes were all up-regulated through all the time points. In addition, HLA-G, a key gene that mediates cellular immune suppression effect, was up-regulated during recovery phases of SMG exposure. Our findings contribute significantly to the knowledge of epidermal response to SMG, which may suggest a mechanism in the whole body response to microgravity, particularly in microgravity-associated immune response suppression, integrated stress response, and tumor progression. Overall, the data suggests, for health's sake, shorter mission duration in space may lead to quicker and more complete recovery from the microgravity effects.

Materials and Methods {#s0055}
=====================

Cell culture {#s0060}
------------

HEK001, an immortalized human skin keratinocyte cell line of basal-like type [@bib45], was purchased from American Type Culture Collection (Manassas, VA, USA) and cultured at 37°C with 95% humidity and 5% CO~2~ in Ketatinocyte-Serum Free medium with 5 ng/mL human recombinant EGF, 50 ug/mL bovine pituitary extract, and 2 mM L-glutamine.

Simulated microgravity and cell exposure {#s0065}
----------------------------------------

Ground-based modeled microgravity was achieved using the 50 mL HARV units of the rotating wall vessel (RWV) culture apparatus (a NASA JSC invention) from Synthecon, Inc (Houston, TX, USA). Cell viability and cell concentration were determined by Vi-Cell 1.01 cell counter of Beckman Coulter (Fullerton, CA, USA). For the 3-day and 4-day modeled microgravity exposures, a density of 2.0×10^5^ cell/mL with viability of 93.2% of the HEK001 cells were cultured in RWV bioreactors at 17.2 rpm to achieve the constant free-fall experience for cell aggregates. At the end of the 3-day and 4-day microgravity exposure, the contents of the bioreactor vessels were poured out into a 50 mL sterile centrifuge tube to collect cell pellets, and 5 mL of the cell suspension from the bioreactor vessels was transferred to T75 flasks for morphological observation and for further stationary culture. Hence, the recovery stage for the exposed cells as well as post 3-day and post 4-day microgravity recovery cell samples were achieved. After the removal of the cells from the vessels, fresh medium was used to refill the vessels for extended microgravity exposure to 9 and 10 d, respectively. The resulted cells were all transferred to stationary culture for recovery of 50 and 60 d, with medium change twice per week. Non-exposed stationary controls and the recovery stage of microgravity-exposed HEK001 cells were cultured in tissue culture flasks with vented caps (TPP Techno Plastic Products, Trasadingen, Switzerland) in the same incubator at 37°C with 5% CO~2~.

Total RNA isolation and DNA microarray hybridization {#s0070}
----------------------------------------------------

HEK001 cells cultured in modeled microgravity HARV bioreactors and control flasks were removed at their respective time points, washed with PBS for three times and lysed in guanidinium isothiocyanate buffer. The cell lysates were stored at ---80°C prior to ultracentrifugation for total RNA isolation [@bib46], [@bib47]. Total cellular RNA was labeled using the Agilent Low RNA Input fluorescent Linear Amplification Kit (Agilent Technologies, Santa Clara, CA, USA) following the manufacturer's protocols [@bib48]. The fluorescently labeled cRNA probes were further purified and hybridized to Agilent 22K Human Microarray V2 according to the specified procedures within the kit.

Microarray scanning, feature extraction, and functional grouping {#s0075}
----------------------------------------------------------------

The microarrays were scanned using a ScanArray microarray scanner (Perkin-Elmer, Waltham, MA, USA). The images generated from the scanning were imported into GenePix 6.0 (Molecular Devices, Sunnyvale, CA, USA) for alignment and initial quantitation. Lowess normalization and some statistical analyses were performed in Acuity 4.0 (Molecular Devices). The normalized genes were then subjected to a student *t*-test to determine statistical significance. An alteration in gene expression level was considered significant if it passed a statistically significant level of *p* ≤0.05 and met the minimum cut-off of 1.5-fold differential regulation. The significant genes thus identified were further processed using EASE [@bib49] to identify 18 functional categories and relevant pathways. The functional categories were then used to organize the gene table ([Table 1](#t0005){ref-type="table"}) and to generate the comparative histograms ([Figure 3](#f0015){ref-type="fig"}).

Hierarchical clustering and Venn diagrams {#s0080}
-----------------------------------------

We also used the average-linkage hierarchical clustering to better organize and visualize the expression patterns in the data [@bib33], [@bib50]. The hierarchical clustering was performed using Genesis 1.0 [@bib51]. To more easily identify the genes affected by all the SMG treatments, we generated Venn diagrams using AFM 4.0 [@bib52].

Northern blotting, normalization, and quantitative analysis {#s0085}
-----------------------------------------------------------

Some of the significantly regulated microgravity sensitive genes identified from the DNA microarray analysis were further verified using Northern blotting. Briefly, 10 *μ*g total RNA was loaded per lane on a 1% formaldehyde agarose gel for electrophoresis separation of RNA species. The gel-separated RNAs were capillarilly transferred onto a nylon membrane, which was subjected to a hybridization procedure using chemilluminascently (Pierce Biotechnology, Rockford, IL, USA) labeled cDNA probe fragments. The blot was sequentially hybridized with ten different probe fragments. The cDNA probe fragments were generated from RT-PCR reactions using total cellular RNA as the templates. RT-PCR reactions were carried out to generate the cDNA probes required for the Northern blotting analysis, using the Reverse Transcription System of Promega (Madison, WI, USA) and the Bio-Line Red DNA Polymerase PCR kit (Taunton, MA, USA). For Northern blot quantitation, the autoradiographs of the Northern blots were scanned and saved as TIF images for further analysis. The images were then opened in Unscan-It Gel (Silk Scientific, Orem, UT, USA) for quantitation. To quantitatively analyze the mRNA levels from the Northern blots, we first normalized the mRNA bands in [Figure 6A−J](#f0030){ref-type="fig"} against the GAPDH level in each corresponding lane. The normalized levels of the mRNA in each panel were then plotted in histograms as shown in [Figure 7](#f0035){ref-type="fig"}.
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Appendix {#s0100}
========

Table 1Identification and clustering of 162 putative gravity sensitive genes[\*](#tbl1fn1){ref-type="table-fn"}Table 1Accession No.Gene symbol1^\#^2^\#^3^\#^4^\#^5^\#^Gene descriptionBiological processCLUSTER INM_001657AREG−11.43−10.721.13−1.73−3.25amphiregulin (schwannoma-derived growth factor)Cell communicationNM_006010ARMET−2.78−2.77−1.43−1.83−1.85arginine-rich, mutated in early stage tumorsUnknownNM_001673ASNS−2.87−3.321.31−3.99−1.59asparagine synthetase (ASNS), transcript variant 2Amino acid metabolismNM_004343CALR−3.08−2.92−1.77−1.49−1.75calreticulinCell cycleNM_014685HERPUD1−4.61−4.44−1.94−3.04−3.52homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1, transcript variant 1Protein metabolismNM_004134HSPA5−4.98−4.25−2.03−2.87−3.49heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa)Cell cycleNM_013417IARS−3.95−3.42−3.87−2.37isoleucine-tRNA synthetase (IARS), transcript variant longProtein metabolismNM_004563PCK2−4.18−4.171.37−3.14−1.88phosphoenolpyruvate carboxykinase 2 (mitochondrial), nuclear gene encoding mitochondrial protein, transcript variant 1Glucose metabolismNM_004911PDIA4−4.28−3.12−2.63−2.42−2.50protein disulfide isomerase family A, member 4UnknownNM_006623PHGDH−2.53−3.631.39−5.59−2.00phosphoglycerate dehydrogenaseDevelopmentNM_022044SDF2L1−3.68−3.46−3.05−2.63stromal cell-derived factor 2-like 1UnknownNM_001005291SREBF1−3.64−4.55−1.30−2.04−1.69sterol regulatory element binding transcription factor 1, transcript variant 1Cellular lipid metabolismNM_003299TRA1−3.26−3.21−1.75−2.20−2.59tumor rejection antigen (gp96) 1Cell cycleNM_021158TRIB3−3.68−4.761.48−5.98−3.09tribbles homolog 3 (Drosophila)UnknownCLUSTER IINM_001605AARS−1.73−1.83−1.01−1.43−1.22alanyl-tRNA synthetaseProtein metabolismNM_001001937ATP5A1−1.64−1.121.04−1.20−1.25ATP synthase, H^+^ transporting, mitochondrial F1 complex, alpha subunit, isoform 1DevelopmentNM_001697ATP5O−2.06−1.931.09−1.39−1.60ATP synthase, H^+^ transporting, mitochondrial F1 complex, O subunitDevelopmentBC000228BC000228−3.02−1.83−2.23−1.41−2.03Similar to transducin-like enhancer of split 1, homolog of Drosophila E (sp1)UnknownNM_032621BEX2−2.86−2.69−1.22−1.57brain expressed X-linked 2UnknownNM_001005266C15orf21−2.40−3.07−1.58−1.43chromosome 15 open reading frame 21, transcript variant 1UnknownNM_001009924C20orf30−1.71−1.11−1.41−1.35chromosome 20 open reading frame 30, transcript variant 2UnknownNM_000071CBS−1.98−1.93−1.91−1.38cystathionine-beta-synthaseAmino acid metabolismNM_014550CARD10−1.47−1.38−1.52−1.29caspase recruitment domain family, member 10Cell cycleNM_004360CDH1−1.52−1.77−1.96−1.63cadherin 1, type 1, E-cadherin (epithelial)Cell adhesionNM_025233COASY−1.51−1.32Coenzyme A synthaseUnknownNM_001316CSE1L−1.26−1.62−1.57−1.52CSE1 chromosome segregation 1-like (yeast), transcript variant 1 Cell cycleD00022D00022−1.57−1.32−1.01−1.33−1.13mRNA for F1 beta subunit, complete cdsUnknownNM_032552DAB2IP−1.24−1.85−1.33−1.19DAB2 interacting protein, transcript variant 1UnknownNM_004394DAP−1.66−1.291.05−1.27−1.13death-associated proteinCell cycleNM_033657DAP3−1.23−1.28−1.01−1.61−1.24death-associated protein 3Cell cycleNM_001919DCI−3.00−3.51−1.55dodecenoyl-Coenzyme A delta isomerase (3,2-trans-enoyl-Coenzyme A isomerase), nuclear gene encoding mitochondrial proteinCellular lipid metabolismNM_001360DHCR7−1.51−1.52−1.51−1.957-dehydrocholesterol reductaseCellular lipid metabolismNM_006824EBNA1BP2−1.56−1.22−1.31−1.09EBNA1 binding protein 2Cell organization and biogenesisNM_006579EBP−1.54−1.58−1.25−1.43emopamil binding protein (sterol isomerase)DevelopmentNM_001398ECH1−1.73−1.63−1.27−1.60enoyl Coenzyme A hydratase 1, peroxisomalCellular lipid metabolismNM_001404EEF1G−1.65−1.51−1.29−1.30−1.44eukaryotic translation elongation factor 1 gammaProtein metabolismNM_013234EIF3S12−1.66−1.28−1.27−1.12eukaryotic translation initiation factor 3, subunit 12UnknownNM_003756EIF3S8−1.45−1.51−1.55−1.62eukaryotic translation initiation factor 3, subunit 3 gamma, 40 kDaProtein metabolismBC047866ENST 00000265423−1.78−1.26−1.12−1.06chromosome 6 open reading frame 62, mRNA (cDNA clone MGC:57512 IMAGE:6499979)UnknownNM_004446EPRS−1.96−1.91−1.24glutamyl-prolyl-tRNA synthetaseProtein metabolismNM_144503F11R−1.10−1.14−1.56−1.36F11 receptorImmune responseNM_004470FKBP2−2.51−2.09−1.09−1.73−1.55FK506 binding protein 2, 13 kDa, transcript variant 1Protein metabolismNM_003910G10−1.59−1.781.16−1.48−1.28maternal G10 transcriptTranscritionNM_002047GARS−1.70−1.611.02−1.56−1.36glycyl-tRNA synthetaseProtein metabolismNM_014394GHITM−1.79−1.88−2.24−1.70growth hormone inducible transmembrane proteinUnknownNM_006098GNB2L1−1.02−1.13−1.26−1.55−1.36guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1Cell communicationNM_000183HADHB−1.57−1.61hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunitCellular lipid metabolismNM_080820HARS2−2.56−1.60−1.31histidyl-tRNA synthetase 2Amino acid metabolismNM_178580HM13−1.49−1.14−1.82−1.51histocompatibility (minor) 13UnknownNM_001540HSPA9B−2.03−1.82−1.12−2.28−1.57heat shock 70 kDa protein 9B (mortalin-2), nuclear gene encoding mitochondrial proteinCell cycleNM_006764IFRD2−1.51−1.42−1.20interferon-related developmental regulator 2DevelopmentNM_000210ITGA6−1.82−1.42−1.10−1.29integrin, alpha 6Cell adhesionNM_002229JUNB−1.19−1.83−1.79−2.13jun B protooncogeneTranscritionNM_015005KIAA0284−1.12−1.26−1.63−1.29KIAA0284UnknownNM_000421KRT10−1.24−1.29−1.05−1.76−1.50keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris)DevelopmentNM_000422KRT171.541.251.371.731.85keratin 17DevelopmentNM_004138KRTHA3A−1.47−1.67−1.30−1.43−1.02keratin, hair, acidic, 3AUnknownNM_005561LAMP1−1.94−1.83−1.23−1.47−1.41lysosomal-associated membrane protein 1UnknownNM_018407LAPTM4B−1.54−1.42−1.34lysosomal-associated protein transmembrane 4 betaUnknownM_002300LDHB−1.33−1.491.08−1.44−1.62lactate dehydrogenase BNGlucose metabolismNM_031484MARVELD1−1.89−2.13−1.53−1.49MARVEL domain containing 1UnknownNM_014874MFN2−1.53−1.48−1.26−1.22mitofusin 2, nuclear gene encoding mitochondrial proteinCell cycleNM_014046MRPS18B−1.90−1.74mitochondrial ribosomal protein S18B, nuclear gene encoding mitochondrial proteinProtein metabolismNM_002467MYC−1.48−2.64−1.74v-myc myelocytomatosis viral oncogene homolog (avian)Cell cycleNM_004559NSEP1−1.38−1.451.24−1.44−1.55nuclease sensitive element binding protein 1TranscritionNM_000918P4HB−1.65−1.63−1.81−1.27procollagen-proline, 2-oxoglutarate 4-dioxygenase, beta polypeptide (protein disulfide isomerase-associated 1)Protein metabolismNM_005742PDIA6−2.35−2.52−1.65−1.46protein disulfide isomerase family A, member 6UnknownNM_024895PDZK7−1.53−1.47−2.11−1.531.02PDZ domain containing 7UnknownNM_203473PORCN−2.87−2.43−1.07−1.49−1.47porcupine homolog (Drosophila) (PORCN), transcript variant BUnknownNM_138689PPP1R14B−1.35−1.401.02−1.49−1.68protein phosphatase 1, regulatory (inhibitor) subunit 14BUnknownNM_000310PPT1−1.97−1.97−1.53−1.43palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile)Protein metabolismNM_012094PRDX5−1.76−1.58−1.07−1.07peroxiredoxin 5, nuclear gene encoding mitochondrial protein, transcript variant 1Immune responseNM_212472PRKAR1A−1.28−1.34−1.52−1.66protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)Cell communicationNM_002862PYGB−2.51−1.55−2.67−1.75phosphorylase, glycogen; brainProtein metabolismNM_000967RPL3−1.56−1.71−1.02−1.51−1.33ribosomal protein L3Protein metabolismNM_000968RPL4−1.45−1.57−1.32−1.36−1.16ribosomal protein L4Protein metabolismNM_033251RPL13−1.25−1.34−1.30−1.74ribosomal protein L13Protein metabolismNM_002948RPL15−1.35−1.571.19−1.53−1.52ribosomal protein L15Protein metabolismNM_033251RPL301.371.351.061.681.42ribosomal protein L30Protein metabolismNM_033625RPL341.471.32−1.301.751.51ribosomal protein L34Protein metabolismNM_053275RPLP0−1.29−1.491.10−1.17−1.55ribosomal protein, large, P0Protein metabolismNM_002950RPN1−2.03−1.65−1.59*Homo sapiens* ribophorin IProtein metabolismNM_001005RPS3−1.57−1.66−1.34−1.18−1.02ribosomal protein S3Protein metabolismNM_183352SEC13L1−1.51−1.26−1.02−1.20SEC13-like 1 (*S. cerevisiae*), transcript variant 2DevelopmentNM_006640SEPT9−1.27−1.78−1.29−1.53septin 9UnknownNM_152264SLC39A14−1.62−1.55−1.29−1.21solute carrier family 39 (zinc transporter), member 13UnknownNM_014426SNX5−1.16−1.26−1.53−1.35Sorting Nexin 5Cell communicationNM_021102SPINT2−1.57−1.671.07−1.14−1.23serine protease inhibitor, Kunitz type, 2Cell motilityNM_003145SSR2−1.22−1.36−1.14−1.58−1.38signal sequence receptor, beta (translocon-associated protein beta)Cell organization and biogenesisNM_003146SSRP1−1.20−1.69−1.22structure specific recognition protein 1TranscritionNM_152295TARS−1.24−1.57−2.05−1.19threonyl-tRNA synthetaseProtein metabolismNM_012458TIMM13−1.63−1.45−1.02−1.07−1.35translocase of inner mitochondrial membrane 13 homolog (yeast), nuclear gene encoding mitochondrial proteinDevelopmentNM_003722TP73L−1.51−2.421.08−1.82−1.40tumor protein p73-likeCell communicationNM_003329TXN1.692.062.211.98thioredoxinCell communicationNM_005080XBP1−1.61−1.68−1.64−1.41X-box binding protein 1TranscritionNM_003404YWHAB−1.58−1.461.49−1.45−1.61tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, transcript variant 1UnknownCLUSTER IIINM_006317BASP11.851.881.881.42brain abundant, membrane attached signal protein 1UnknownNM_000610CD441.831.781.521.921.31CD44 antigenCell adhesionNM_133467CITED42.192.322.021.67Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4TranscritionNM_024045DDX501.711.631.47DEAD (Asp-Glu-Ala-Asp) box polypeptide 50UnknownNM_001967EIF4A22.281.981.411.63eukaryotic translation initiation factor 4A, isoform 2Protein metabolismNM_004004GJB22.491.951.472.21gap junction protein, beta 2, 26 kDa (connexin 26)Cell communicationNM_004832GSTO12.524.802.73glutathione S-transferase omega 1UnknownNM_005345HSPA1A2.062.141.381.46heat shock 70 kDa protein 1ACell cycleNM_006644HSPH11.551.611.21heat shock 105 kDa/110 kDa protein 1Protein metabolismNM_002658PLAU2.222.852.301.87plasminogen activator, urokinaseCell communicationNM_002835PTPN122.052.431.24protein tyrosine phosphatase, non-receptor type 12Protein metabolismNM_002872RAC22.893.882.10ras-related C3 botulinum toxin substrate 2Cell communicationNM_000539RHO1.741.69rhodopsin (opsin 2, rod pigment)Cell communicationNM_020150SARA11.751.842.04SAR1a gene homolog 1 (*S. cerevisiae*)Cell communicationNM_021199SQRDL1.901.921.591.38sulfide quinone reductase-like (yeast)UnknownNM_020182TMEPAI1.732.341.592.481.80transmembrane, prostate androgen induced RNA, transcript variant 1Cell communicationNM_005499UBA21.671.481.101.21SUMO-1 activating enzyme subunit 2Protein metabolismCLUSTER IVNM_005946MT1A1.641.521.854.112.26metallothionein 1A (functional)UnknownNM_005947MT1B1.721.842.375.002.70metallothionein 1B (functional)UnknownNM_175617MT1E1.491.632.334.402.81metallothionein 1E (functional)UnknownNM_005950MT1G1.921.882.255.232.71metallothionein 1GUnknownNM_005951MT1H1.871.842.284.682.68metallothionein 1HUnknownNM_005952MT1X1.881.762.284.542.48metallothionein 1XDevelopmentNM_005953MT2A2.212.092.576.382.86metallothionein 2AMetal ion homeostasisBC007034ENST 000002451852.262.142.355.953.20metallothionein 2A, mRNA (cDNA clone MGC:12397 IMAGE:4051220)Metal ion homeostasisCLUSTER VNM_001101ACTB1.191.141.211.511.29actin, betaCell cycleNM_001102ACTN12.082.23actinin, alpha 1UnknownNM_004039ANXA21.261.321.201.551.29Annexin A2DevelopmentNM_006476ATP5L1.411.231.831.64ATP synthase, H^+^ transporting, mitochondrial F0 complex, subunit g, nuclear gene encoding mitochondrial proteinPhophorylationNM_178508C6orf11.391.341.981.67chromosome 6 open reading frame 1UnknownNM_016289CAB392.011.77calcium binding protein 39UnknownNM_006367CAP11.471.441.841.30adenylate cyclase-associated protein 1 (yeast)UnknownNM_152221CSNK1E1.601.221.161.601.33casein kinase 1, epsilon, transcript variant 1Cell communicationAK074742ENST 00000361624−2.28−1.38−2.38−1.49−2.09cDNA FLJ90261 fis, clone NT2RM4000761UnknownNM_001997FAU1.151.101.031.531.60Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived); ribosomal protein S30 (FAU)Protein metabolismNM_001436FBL−1.24−1.57−1.03−1.14fibrillarinRNA metabolismM90686HLA-G2.953.24lymphocyte antigen (HLA-G3)Immune responseNM_001540HSBP11.861.871.92heat shock 27 kDa protein 1TranscritionNM_000576IL1B1.251.412.261.39interleukin 1, betaImmune responseNM_002192INHBA1.401.553.201.77inhibin, beta A (activin A, activin AB alpha polypeptide)Cell cycleNM_002305LGALS11.551.181.222.251.36lectin, galactoside-binding, soluble, 1 (galectin 1)Cell communicationNM_004528MGST32.231.59microsomal glutathione S-transferase 3Immune responseNM_079423MYL61.491.40−1.242.121.67myosin, light polypeptide 6, alkali, smooth muscle and non-muscleDevelopmentNM_004552NDUFS51.191.25−1.071.581.63NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15 kDa (NADH-coenzyme Q reductase) (NDUFS5)PhophorylationNM_002624PFDN51.551.091.681.37prefoldin 5, transcript variant 1Protein metabolismNM_007273PHB2−1.66−1.501.11−1.68−1.76prohibitin 2UnknownNM_021128POLR2L1.341.331.911.45polymerase (RNA) II (DNA directed) polypeptide L, 7.6 kDaTranscritionNM_002791PSMA61.411.181.911.92proteasome (prosome, macropain) subunit, alpha type, 6Protein metabolismNM_006263PSME11.041.292.091.85proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)Immune responseNM_006907PYCR1−2.57−1.89−1.00−1.47−1.36pyrroline-5-carboxylate reductase 1, transcript variant 1DevelopmentNM_175744RHOC1.301.281.571.28ras homolog gene family, member CUnknownNM_001026RPS241.331.31−1.191.711.68ribosomal protein S24Protein metabolismNM_005979S100A131.621.631.641.38S100 calcium binding protein A13, transcript variant 2DevelopmentNM_005978S100A21.261.24−1.272.291.59S100 calcium binding protein A2DevelopmentNM_001018108SERF21.271.491.091.711.78small EDRK-rich factor 2UnknownNM_004607TBCA1.531.321.631.50tubulin-specific chaperone aProtein metabolismNM_207013TCEB21.221.261.851.89transcription elongation factor B (SIII), polypeptide 2 (18 kDa, elonginProtein metabolismTHC2276562THC22765621.241.69−1.311.962.56limbic system-associated membrane proteinUnknownNM_021103TMSB101.401.271.091.761.38thymosin, beta 10Cell organization and biogenesisNM_000365TPT11.641.26−1.341.731.43triosephosphate isomerase 1Cell cycleNM_006086TUBB31.661.561.711.52tubulin, beta 3UnknownNM_006701TXNL4A−1.21−1.18−1.59−1.23thioredoxin-like 4AUnknownNM_024292UBL51.461.572.211.87ubiquitin-like 5Protein metabolismNM_003761VAMP81.191.231.661.72vesicle-associated membrane protein 8Protein metabolismNM_006373VAT11.861.692.231.58vesicle amine transport protein 1 homolog (T californica)DevelopmentNM_006887ZFP36L22.372.54zinc finger protein 36, C3H type-like 2Cell proliferation[^1]
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![Morphology of HEK001 cells cultured in HARV bioreactors for SMG treatment and in conventional 2D cell culture flasks for normal gravity recovery. **A** and **B**. HEK001 cells cultured in normal gravity tissue culture flasks showing different photo fields and magnifications of the control cells. **C**. Cell aggregates from 3-day SMG culture. **D**. Cells recovering from 3-day SMG treatment in Panel C by 15-day growth in normal (1 *g*) gravity (culture flasks). **E**. Cell aggregates from 4-day SMG treatment. **F**. Cells recovering from 4-day SMG treatment through 15-day culture in normal gravity. **G**. Cells after 7-day recovery in normal gravity from 9-day SMG treatment. **H**. Cells after 16-day recovery in normal gravity from 10-day SMG treatment.](gr1){#f0005}

![MA scatter plots showing the average trend of the log ratio as a function of intensity of features in Arrays 1−5 using Lowess normalization. Each point represents one feature from the corresponding microarray. F633 represents the intensity of the red (R) laser wavelength (633 nm) that excites the cyanine 5 dye. F545 represents the intensity of the green (G) laser wavelength (545 nm) that excites the cyanine 3 dye. The MA plot shows the log intensity ratio M=log~2~(R/G) versus the average intensity A= ½(log~2~R+log~2~G). **A**. MA plot for 3-day SMG (Array 1). **B**. MA plot for 4-day SMG (Array 2). **C**. MA plot for 4-day SMG followed by 15-day recovery at 1 *g* (Array 3). **D** and **E**. MA plots for 9-day and 10-day SMG followed by 50-day and 60-day recovery at 1 *g*, respectively (Arrays 4 and 5).](gr2){#f0010}

![Functional grouping and time course expression profiles of gravity sensitive genes. The gene expression profiles of the 162 putative gravity sensitive genes that were statistically significant (*p*≤0.05) and showed at least 1.5-fold up- or down-regulation from the five experiments were categorized into 18 functional groups and displayed as histograms. The red histograms represent the up-regulated genes and the blue histograms represent down-regulated genes. **A**. Category of 101 differentially regulated genes exposed to 3-day SMG. **B**. Category of 93 differentially regulated genes exposed to 4-day SMG. Note that the patterns of gene regulation exhibited in Panels A and B are very similar. **C**. Category of 18 differentially genes exposed to 4-day SMG followed by 15-day recovery at 1 *g*. **D**. Category of 105 differentially regulated genes exposed to 9-day SMG followed by 50-day recovery. **E**. Category of 95 differentially regulated genes exposed to 10-day SMG followed by 60-day recovery.](gr3){#f0015}

![Cluster analysis of 162 differentially regulated genes from five microarray experiments showing the trend in time course. **A**. The average-linkage hierarchal clustering of the expression data (log~2~) of all the 162 significant genes. The rows represent individual genes categorized into five hierarchical clusters according to differential expression levels. The columns represent the five microarray experiments showing the gene expression pattern for each time point according to the five clusters. **B**. The time course trend of expression of all of the genes represented in each cluster.](gr4){#f0020}

![Venn diagrams of overlapping gene expression patterns of the 162 significant genes across the five time points. The red numbers represent up-regulated genes and the blue numbers represent down-regulated genes. **A**. Comparison of gene expression data of 3-day and 4-day SMG exposure with 4-day SMG exposure followed by 15-day recovery at 1 *g*. **B**. Comparison of gene expression data of 3-day and 4-day SMG exposure with 9-day SMG followed by 50-day recovery and 10-day SMG followed by 60-day recovery. The center of the Venn diagrams shows that there are 32 differentially regulated genes between all four array experiments. **C**. Heat map of the expression pattern for the 32 differentially regulated genes identified from the center of the Venn diagrams in Panel B.](gr5){#f0025}

![Validation of microarray results using Northern blotting analysis of genes differently expressed under modeledmicrogravity conditions. An amount of 10 *μ*g total RNA from each sample was loaded onto a 1% formaldehyde agarosegel. Lanes 1−7 were loaded with samples as the following: Lane 1, conventional stationary control; Lane 2, three-day modeled microgravity; Lane 3, four-day modeled microgravity; Lane 4, three-day microgravity recovery; Lane 5, four-day microgravity recovery; Lane 6, nine-day microgravity recovery; Lane 7, ten-day microgravity recovery. The Northern blot was sequentially hybridized with ten different probes as indicated in Panels A−J: **A**. PDIA4; **B**. MT1X; **C**. TRIB3; **D**. AREG; **E**. MT2A: **F**. TRA1; **G**. MT1A: **H**. PCK2; **I**. ARMET; **J**. GAPDH. The expected mRNA bandfor each probe was indicated with an arrow to the right side of each panel.](gr6){#f0030}

![Quantitative comparison of gene expression data obtained from Northern blotting analysis and microarray analysis. The mRNA bands in [Figure 6A−J](#f0030){ref-type="fig"} were first normalized against the GAPDH level in each corresponding lane. The normalized levels of the mRNA in each panel were then plotted in histograms as shown in [Figure 7A−I](#f0035){ref-type="fig"}. In the histograms, the Northern blotting data (blue) were plotted side by side with the microarray data (red) to directly compare the expression levels of the same nine significant genes. The values of the correlation coefficient (R values) for each comparison were indicated in each panel.](gr7){#f0035}

[^1]: A total of 162 genes were identified from the five SMG experiments to be significantly (≥1.5-fold change, *p* ≤0.05) differentially expressed. They were further categorized into 5 clusters and 18 functional groups. ^\#^1. Regulation value of 3-day SMG. ^\#^2. Regulation value of 4-day SMG. ^\#^3. Regulation value of 4-day SMG plus 15-day recovery. ^\#^4. Regulation value of 9-day SMG plus 50-day recovery. ^\#^5. Regulation value of 10-day SMG plus 60-day recovery.
